4 Sept 2025·Department of Health and Social Care·Answered
AskedIf he will make an assessment of the potential impact of new research into the hepatotoxicity risk posed by kava on The Kava-kava in Food (England) Regulations 2002.
ReplyThe Kava-kava in Food (England) Regulations 2002 prohibits any food consisting of or containing kava-kava from being imported or placed on the market. This regulation is in place to protect public health. Since the introduction of this legislation, any additional scientific evidence that has been provided to the Food Standards Agency (FSA) has not been sufficient to support any amendments to the controls in place. If additional data on the safety of kava-kava were to be submitted, appropriate evaluations, such as a risk assessment, will be considered by the FSA. The outputs of a risk assessment could then be used to provide advice to Ministers, to amend or repeal the legislation. New scientific evidence on the hepatotoxic risk of kava-kava would be reviewed by the FSA. Without additional evidence that indicates a safe level of human consumption for kava-kava, the FSA considers there is insufficient toxicological data available to initiate an assessment. While there is no specific provision in the regulation that sets out the procedure for revoking the controls, as safety concerns provide the basis for the ban, an assessment of newly available data on the safety of kava-kava for human consumption would be the first step. If the independent Committee on the Toxicity of Chemicals in Food, Consumer Products and the Environment is satisfied that there is a safe level of human consumption, this would inform advice to Ministers to amend or repeal the legislation. Any future evaluation of the Kava-kava in Food (England) Regulations 2002, would need to be considered and carried out in tandem with the Medicines and Healthcare products Regulatory Agency as The Medicines for Human Use (Kava-kava) (Prohibition) Order 2002 is applicable.
4 Sept 2025·Department of Health and Social Care·Answered
AskedWhether his Department has made a recent assessment of the adequacy of controls on the (a) sale and (b) import of kava for food purposes in The Kava-kava in Food (England) Regulations 2002.
ReplyThe Kava-kava in Food (England) Regulations 2002 prohibits any food consisting of or containing kava-kava from being imported or placed on the market. This regulation is in place to protect public health. Since the introduction of this legislation, any additional scientific evidence that has been provided to the Food Standards Agency (FSA) has not been sufficient to support any amendments to the controls in place. If additional data on the safety of kava-kava were to be submitted, appropriate evaluations, such as a risk assessment, will be considered by the FSA. The outputs of a risk assessment could then be used to provide advice to Ministers, to amend or repeal the legislation. New scientific evidence on the hepatotoxic risk of kava-kava would be reviewed by the FSA. Without additional evidence that indicates a safe level of human consumption for kava-kava, the FSA considers there is insufficient toxicological data available to initiate an assessment. While there is no specific provision in the regulation that sets out the procedure for revoking the controls, as safety concerns provide the basis for the ban, an assessment of newly available data on the safety of kava-kava for human consumption would be the first step. If the independent Committee on the Toxicity of Chemicals in Food, Consumer Products and the Environment is satisfied that there is a safe level of human consumption, this would inform advice to Ministers to amend or repeal the legislation. Any future evaluation of the Kava-kava in Food (England) Regulations 2002, would need to be considered and carried out in tandem with the Medicines and Healthcare products Regulatory Agency as The Medicines for Human Use (Kava-kava) (Prohibition) Order 2002 is applicable.
4 Sept 2025·Department for Education·Answered
AskedWhether she has made an assessment of the potential merits of adding Ukrainian language GCSE to the curriculum.
ReplyDecisions about which languages to offer at GCSE in England are taken by four independent awarding organisations, AQA, OCR, Pearson Edexcel and WJEC, rather than by central government. These organisations have the freedom to create a Ukrainian GCSE based on the subject content for modern foreign languages set by the department. We have written to these organisations to ask them to consider introducing a Ukrainian GCSE.The British government stands steadfast behind the Ukrainian people and the Ukrainian government. The department is proud to support children and families from Ukraine during their transition to a new life in the UK. To do our part to support the Ukrainian people, we are supporting the Ukrainian Ministry of Education and Science in policy development and this year have launched a UK-Ukraine Schools Partnership programme, twinning 100 schools in the UK and Ukraine.
29 Aug 2025·Treasury·Answered
AskedIf she will remove the tax-exempt heritage assets scheme from landowners.
ReplyThe conditional exemption tax incentive scheme was introduced to preserve and protect the national heritage for the benefit of the public. The Government keeps all tax policy under review, and any changes are set out at fiscal events.
29 Aug 2025·Ministry of Housing, Communities and Local Government·Answered
AskedCommunities and Local Government, what steps she plans to take to encourage empty homes to become occupied.
ReplyI refer the hon. Member to the answer given to Question UIN 59458 on 20 June 2025.
22 Jul 2025·Department for Environment, Food and Rural Affairs·Answered
AskedFood and Rural Affairs, whether his Department has allocated funding to (a) local authorities and (b) other responsible organisations to (i) maintain and (ii) improve rural walking paths.
ReplyThe Government recognises the vital role that public rights of way play in promoting access to nature, encouraging active travel, and supporting community wellbeing. Responsibility for managing and maintaining these routes lies with local highway authorities, who must ensure that paths are clear of obstructions and accessible to all users. Each authority is required to maintain a Rights of Way Improvement Plan (ROWIP), which outlines their strategy for enhancing the local rights of way network. These plans include assessments of the network’s current condition and are made publicly available on the authority’s website. ROWIPs serve as valuable tools for identifying local needs and priorities, including opportunities to improve accessibility for people with disabilities, families, and underrepresented groups. Local authorities are uniquely positioned to understand the specific needs of their communities and to allocate resources effectively. Their local insight ensures that improvements to the rights of way network are both targeted and impactful. The Government continues to collaborate with partners to support responsible access and promote inclusive enjoyment of the natural environment.
21 Jul 2025·Department of Health and Social Care·Answered
AskedWhat steps he has taken to raise awareness among (a) people sleeping rough, (b) socially isolated people and (c) other at-risk populations on the dangers of synthetic opioids since 2024.
ReplyThe Department of Health and Social Care (DHSC) has issued planning guidance for local areas to help them respond to incidents caused by potent synthetic opioids. The guidance enables local partners to rapidly understand the scale of the synthetic opioid threat and assess the risk, communicate the threat, and take actions to mitigate it.The Combating Drugs Partnerships (CDP) are vital in leading the local response to synthetic opioids and developing preparedness plans to manage the risk in their area, utilising the local guidance issued by the Department. In addition to a tabletop exercise conducted with a range of relevant local partners, a sample of CDP preparedness plans have been analysed by the Government, and the Home Office has published a report which includes a series of recommendations to help local areas maintain their emergency preparation and response.Local authorities are responsible for commissioning drug and alcohol services according to local need and it is for local authorities to decide on the amount of funding to dedicate to public education on the risks of synthetic opioids and how to respond to an opioid overdose. DHSC has made clear that local authorities can allocate funding to support campaigns and events to improve understanding and reduce harm. In addition, in response to increasing use and the serious harms associated with synthetic opioids, the Department is planning a public health awareness campaign which will launch in the coming months. This campaign will raise awareness of new patterns of drug use and their associated risks.To ensure that vulnerable at-risk groups, including the homeless and those who are socially isolated, are aware of the dangers these drugs pose, regular drug alerts and communications are circulated by DHSC to commissioners and providers of drug treatment services, and there is ongoing engagement with local drug systems across England that are responsible for ensuring relevant professionals within their areas are adequately informed. It is their responsibility to circulate information with wider local stakeholders, such as the homelessness sector.DHSC also includes advice on how to respond when witnessing an opioid overdose in its naloxone guidance and on the Government’s drugs information website, Talk to FRANK.
21 Jul 2025·Department of Health and Social Care·Answered
AskedWhat steps he has taken to integrate synthetic opioid awareness into local authorities’ Drug Strategies since 5 July 2025; and how much of the 2025/26 targeted drug, alcohol treatment and recovery grant funding for local authorities in England, announced on 31 March 2025 he has allocated to public education on the (a) risks of synthetic opioids and (b) how to respond when witnessing an opioid overdose.
ReplyThe Department of Health and Social Care (DHSC) has issued planning guidance for local areas to help them respond to incidents caused by potent synthetic opioids. The guidance enables local partners to rapidly understand the scale of the synthetic opioid threat and assess the risk, communicate the threat, and take actions to mitigate it.The Combating Drugs Partnerships (CDP) are vital in leading the local response to synthetic opioids and developing preparedness plans to manage the risk in their area, utilising the local guidance issued by the Department. In addition to a tabletop exercise conducted with a range of relevant local partners, a sample of CDP preparedness plans have been analysed by the Government, and the Home Office has published a report which includes a series of recommendations to help local areas maintain their emergency preparation and response.Local authorities are responsible for commissioning drug and alcohol services according to local need and it is for local authorities to decide on the amount of funding to dedicate to public education on the risks of synthetic opioids and how to respond to an opioid overdose. DHSC has made clear that local authorities can allocate funding to support campaigns and events to improve understanding and reduce harm. In addition, in response to increasing use and the serious harms associated with synthetic opioids, the Department is planning a public health awareness campaign which will launch in the coming months. This campaign will raise awareness of new patterns of drug use and their associated risks.To ensure that vulnerable at-risk groups, including the homeless and those who are socially isolated, are aware of the dangers these drugs pose, regular drug alerts and communications are circulated by DHSC to commissioners and providers of drug treatment services, and there is ongoing engagement with local drug systems across England that are responsible for ensuring relevant professionals within their areas are adequately informed. It is their responsibility to circulate information with wider local stakeholders, such as the homelessness sector.DHSC also includes advice on how to respond when witnessing an opioid overdose in its naloxone guidance and on the Government’s drugs information website, Talk to FRANK.
21 Jul 2025·Department of Health and Social Care·Answered
AskedWhat assessment he has made of the effectiveness of local Combating Drugs Partnerships in raising awareness of (a) synthetic opioids and (b) how to respond when witnessing an opioid overdose; and what plans he has to roll out best practice on that issue.
ReplyThe Department of Health and Social Care (DHSC) has issued planning guidance for local areas to help them respond to incidents caused by potent synthetic opioids. The guidance enables local partners to rapidly understand the scale of the synthetic opioid threat and assess the risk, communicate the threat, and take actions to mitigate it.The Combating Drugs Partnerships (CDP) are vital in leading the local response to synthetic opioids and developing preparedness plans to manage the risk in their area, utilising the local guidance issued by the Department. In addition to a tabletop exercise conducted with a range of relevant local partners, a sample of CDP preparedness plans have been analysed by the Government, and the Home Office has published a report which includes a series of recommendations to help local areas maintain their emergency preparation and response.Local authorities are responsible for commissioning drug and alcohol services according to local need and it is for local authorities to decide on the amount of funding to dedicate to public education on the risks of synthetic opioids and how to respond to an opioid overdose. DHSC has made clear that local authorities can allocate funding to support campaigns and events to improve understanding and reduce harm. In addition, in response to increasing use and the serious harms associated with synthetic opioids, the Department is planning a public health awareness campaign which will launch in the coming months. This campaign will raise awareness of new patterns of drug use and their associated risks.To ensure that vulnerable at-risk groups, including the homeless and those who are socially isolated, are aware of the dangers these drugs pose, regular drug alerts and communications are circulated by DHSC to commissioners and providers of drug treatment services, and there is ongoing engagement with local drug systems across England that are responsible for ensuring relevant professionals within their areas are adequately informed. It is their responsibility to circulate information with wider local stakeholders, such as the homelessness sector.DHSC also includes advice on how to respond when witnessing an opioid overdose in its naloxone guidance and on the Government’s drugs information website, Talk to FRANK.
18 Jul 2025·Department of Health and Social Care·Answered
AskedWhat information his Department holds on the potential impact of (a) diamorphine assisted therapy, (b) safe consumption rooms and (c) other drug harm reduction services on the level of ambulance call-outs.
ReplyHarm reduction measures are vital and can have an impact on preventing overdoses, reducing the spread of infections, and engaging people into drug treatment. However, most of these outcomes would not be seen in ambulance data. The Department does not collect information on the potential impact of diamorphine assisted therapy (DAT), safe consumption rooms and other harm reduction services on the level of ambulance call outs. Identifying the impact of interventions typically delivered to small groups within broader populations at risk of overdose on ambulance call outs would be challenging due to other factors influencing overall levels and it is unlikely to be possible to do this robustly within an English context.
15 Jul 2025·Department for Transport·Answered
AskedHow she plans to roll out at-home electric vehicle charging points for people in terrace housing with no off-street parking.
ReplyThe Department is working with local authorities to encourage the use of cross-pavement solutions and on the 13 July, announced the £25m Electric Vehicle Pavement Channel grant to further support local authorities in England to adopt pavement channels. This will allow EV drivers to access their domestic electricity tariffs by safely connecting a home EV charger to their vehicle parked on-street and adds to published local authority guidance and home charging grants that the Government already provides.
14 Jul 2025·Department for Environment, Food and Rural Affairs·Answered
AskedFood and Rural Affairs, what steps he plans to take to encourage the recycling of re-usable vapes once they have reached end-of-use.
ReplySince April 2024, businesses selling vapes have been legally required to offer in-store takeback, making recycling vapes accessible for consumers and preventing vapes being littered or incorrectly disposed of. In addition, the Government is introducing legislation to create a new category of Electrical and Electronic Equipment for vapes, to ensure that the costs of collection and treatment fall fairly on those who produce them. As part of the Waste Electrical and Electronic Equipment Regulations, producers can pay into a Producer Compliance Fee, funding consumer awareness campaigns including on the correct disposal of vapes. You can find your nearest recycling location online by searching "Recycle Your Electricals."
10 Jul 2025·Department of Health and Social Care·Answered
AskedWhat proportion of applications to the vaccine damage payment scheme since 2020 have been successful on appeal,by vaccine type.
ReplyData from the NHS Business Services Authority, the administrators of the Vaccine Damage Payment Scheme (VDPS), shows that 22,408 VDPS claims were received between 1 November 2021 and 4 July 2025. 1.1% of these have been successful, with a further 0.1% having been successful following an appeal, known as a mandatory reversal. Of the claims received:21,213 of these were for claims related to vaccination against COVID-19. 1.1% of these claims have been successful, with a further 0.1% having been successful after a mandatory reversal request;171 claims were received in relation to vaccination against flu in adults. 1.8% of these claims have been successful, and none of these claims were successful after a mandatory reversal; and1,024 claims were received in relation to vaccination against other diseases. 0.7% of these claims have been successful, and none of these claims were successful after a mandatory reversal.These figures are based on total applications received. Some of these applications will not yet have been assessed or were invalid.
10 Jul 2025·Department of Health and Social Care·Answered
AskedWhat proportion of applications to the vaccine damage payment scheme since 2020 have been successful, by vaccine type.
ReplyData from the NHS Business Services Authority, the administrators of the Vaccine Damage Payment Scheme (VDPS), shows that 22,408 VDPS claims were received between 1 November 2021 and 4 July 2025. 1.1% of these have been successful, with a further 0.1% having been successful following an appeal, known as a mandatory reversal. Of the claims received:21,213 of these were for claims related to vaccination against COVID-19. 1.1% of these claims have been successful, with a further 0.1% having been successful after a mandatory reversal request;171 claims were received in relation to vaccination against flu in adults. 1.8% of these claims have been successful, and none of these claims were successful after a mandatory reversal; and1,024 claims were received in relation to vaccination against other diseases. 0.7% of these claims have been successful, and none of these claims were successful after a mandatory reversal.These figures are based on total applications received. Some of these applications will not yet have been assessed or were invalid.
10 Jul 2025·Department of Health and Social Care·Answered
AskedHow many applications have been made to the vaccine damage payment scheme since 2020, by vaccine type.
ReplyData from the NHS Business Services Authority, the administrators of the Vaccine Damage Payment Scheme (VDPS), shows that 22,408 VDPS claims were received between 1 November 2021 and 4 July 2025. 1.1% of these have been successful, with a further 0.1% having been successful following an appeal, known as a mandatory reversal. Of the claims received:21,213 of these were for claims related to vaccination against COVID-19. 1.1% of these claims have been successful, with a further 0.1% having been successful after a mandatory reversal request;171 claims were received in relation to vaccination against flu in adults. 1.8% of these claims have been successful, and none of these claims were successful after a mandatory reversal; and1,024 claims were received in relation to vaccination against other diseases. 0.7% of these claims have been successful, and none of these claims were successful after a mandatory reversal.These figures are based on total applications received. Some of these applications will not yet have been assessed or were invalid.
9 Jul 2025·Department for Education·Answered
AskedIf she will review the statutory walking distance for free school transport.
ReplyThe department’s home-to-school travel policy aims to make sure that no child is prevented from accessing education by a lack of transport.Local authorities must arrange free home-to-school travel for children of compulsory school age, 5 to 16, who attend their nearest school and would not be able to walk there due to the distance, their special educational needs, disability or mobility problem, or because the nature of the route means it would be unsafe for them to do so. There are extended rights to free travel for children from low-income families, intended to help them exercise school choice.The government is committed to creating opportunities for all children so that they can achieve and thrive and is working with department officials to understand how well home-to-school travel supports children to access educational opportunity.
8 Jul 2025·Department of Health and Social Care·Answered
AskedWhat steps he plans to take to increase the uptake of measles vaccines.
ReplyThe Department is working alongside its partners to increase vaccine uptake across all childhood vaccination programmes, including the measles, mumps, and rubella (MMR) programme.In light of a surge in measles cases in the North West, the UK Health Security Agency and the National Health Service are working with local partners to monitor the situation, provide advice, and support local communities to be aware of action they can take to protect themselves, including getting vaccinated.Building on the MMR coverage gains achieved in 2023/4, NHS England continues to deliver national and regional improvement plans that include activities to strengthen the routine vaccination offer and to address inequalities by supporting MMR catch up vaccination by school age vaccination services in schools and community settings. For example, summer ‘catch up’ immunisation clinics are being stood in some of the areas with the lowest MMR uptake including Liverpool, Knowsley, Sefton, and St Helens.National childhood vaccination communication campaigns are planned in August and September 2025 for children returning to school. This will be a re-launch of the 2024 childhood vaccination campaign aimed at increasing the awareness of childhood vaccinations and encouraging parents to book catch-up appointments.It is vitally important that everyone takes up the vaccinations they are entitled to, for themselves, their families, and wider society. The MMR vaccine is highly effective, safe, and is the best way to prevent measles.
30 Jun 2025·Department for Work and Pensions·Answered
AskedPursuant to the Answer of 27 June 2025 to Question 61211 on Asbestos: Ovarian Cancer, if she will direct the Health and Safety Executive to collect data on asbestos-related ovarian cancer cases.
ReplyCollecting data on individual cases of asbestos-related ovarian cancer is not feasible due to difficulties attributing them to historic exposure with confidence. Significant resource would be needed to produce estimates based on epidemiological evidence. These are likely to be small in comparison to other asbestos-related diseases such as mesothelioma (which is more clearly linked to past exposure) and would have considerable associated uncertainty.
24 Jun 2025·Ministry of Housing, Communities and Local Government·Answered
AskedCommunities and Local Government, if she will make it her policy to provide free menstrual products to homelessness shelters.
ReplyThe Government does not directly commission homelessness shelters or services. In 2025/26 the Government is investing £1 billion in homelessness services, an increase of £233 million on the previous year. Local authorities can use this funding to provide a range of services to meet local need, which may include the provision of menstrual and other sanitary products.
24 Jun 2025·Department of Health and Social Care·Answered
AskedWhat information his Department holds on the impact of (a) diamorphine assisted therapy, (b) safe consumption rooms and (c) needle and syringe exchange services on rates of skin and soft tissue infection.
ReplyThe Department does not collect information on the impact of diamorphine assisted therapy (DAT), safe consumption rooms and needle and exchange services on rates of soft skin tissue infections (SSTI). The Department is aware of the dangers of SSTI to people who inject drugs and in 2021 issued guidance for commissioners and providers of drugs services on being ‘wound aware’. This recommends that a range of local services can help prevent SSTIs and stop them getting worse through early identification and treatment.DAT is an option that remains open to local areas under the existing legal framework, where the relevant licences are obtained from the Home Office. There is good evidence that needle and syringe programmes alongside opioid substitution treatment are associated with reduced rates of HIV and hepatitis C infection in the target population. The review of the evidence is available at the following link:https://www.gov.uk/government/publications/drug-misuse-treatment-in-england-evidence-review-of-outcomes